Company profile for Renalytix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Renalytix is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare cos...
Renalytix is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Our goal is to lower healthcare costs and improve patient quality of life by transforming the paradigm for kidney disease risk assessment and clinical management through our KidneyIntelX platform.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1460 Broadway New York, NY
Telephone
Telephone
+1 (415) 389-6400
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/07/11/2911676/0/en/Renalytix-and-Steno-Diabetes-Center-Announce-Precision-Medicine-Collaboration-Marking-First-Expansion-for-KidneyIntelX-Platform-Beyond-US.html

GLOBENEWSWIRE
11 Jul 2024

https://www.globenewswire.com/news-release/2024/06/27/2905606/0/en/Renalytix-Submits-Hearing-Request-to-Nasdaq-Hearings-Panel-in-Regard-to-Staff-Delisting-Determination.html

GLOBENEWSWIRE
27 Jun 2024

https://www.globenewswire.com/news-release/2024/05/15/2882289/0/en/Renalytix-Reports-Financial-Results-for-Third-Quarter-of-Fiscal-Year-2024.html

GLOBENEWSWIRE
15 May 2024
Renalytix Q3 FY2024 Results On May 15
Renalytix Q3 FY2024 Results On May 15

09 May 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/05/09/2878585/0/en/Renalytix-to-Report-Financial-Results-for-Third-Quarter-Fiscal-Year-2024-on-May-15.html

GLOBENEWSWIRE
09 May 2024

https://www.globenewswire.com/news-release/2024/04/08/2859063/0/en/Renalytix-Announces-Financing-with-Expected-Size-of-up-to-4-Million.html

GLOBENEWSWIRE
08 Apr 2024

https://www.globenewswire.com//news-release/2024/02/15/2829829/0/en/Renalytix-Reports-Financial-Results-for-Second-Quarter-of-Fiscal-Year-2024.html

GLOBENEWSWIRE
15 Feb 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty